Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Jan 21 2025

0mins

LSH+0.92%

Should l Buy LSH?

Source: Newsfilter

New Distribution Agreements: Lakeside Holding Limited's subsidiary, Hupan Pharmaceutical, has signed two distribution agreements with Hubei Kelun Pharmaceutical Trading Co., Ltd. to distribute large-volume parenteral solutions and related medical products across China for 2025.
Strengthening Market Position: These agreements build on previous partnerships, enhancing Hupan Pharmaceutical's portfolio and solidifying its role in the pharmaceutical distribution sector within the Asia-Pacific market.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy LSH?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on LSH

About LSH

Lakeside Holding Limited is an integrated cross-border supply chain solution provider with a strategic focus on the Asian market, including China and South Korea. The Company primarily provides customized cross-border ocean freight solutions and airfreight solutions in the United States that specifically cater to its customer's requirements and needs in transporting goods into the United States. It offers a variety of integrated services under its cross-border ocean freight solutions and cross-border airfreight solutions, including cross-border freight consolidation and forwarding services, customs clearance services, warehousing and distribution services and United States domestic ground transportation services. It operates two regional warehousing and distribution centers in the United States, in Illinois and Texas. The Company’s customers are typically Asia and United States-based logistics service companies serving e-commerce platforms, social commerce platforms, and others.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Lakeside Holding files to sell 7.4M shares of common stock for holders

Mar 19 2025Business Insider

Lakeside Holding Stock Offering: Lakeside Holding (LSH) has filed to sell 7.4 million shares of common stock for its holders.
Recent Company Developments: The company has announced board resignations and appointments, as well as secured new distribution agreements with Kelun Pharmaceutical.

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION

Mar 05 2025Newsfilter

Securities Purchase Agreement: Lakeside Holding Limited has entered into a securities purchase agreement to sell up to $4.5 million in senior secured convertible promissory notes, with the first tranche generating approximately $930,000 in gross proceeds.
Company Overview: Lakeside is a U.S.-based supply chain solution provider focused on the Asia-Pacific market, operating through its subsidiaries American Bear Logistics and Hupan Pharmaceutical, enhancing its logistics capabilities in both general and pharmaceutical sectors.

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

Feb 14 2025PRnewswire

Financial Performance: Lakeside Holding Limited reported a 31.3% decrease in total revenues for Q2 2025, primarily due to a decline in cross-border airfreight solutions, resulting in a net loss of $1.9 million compared to a net income of $0.06 million in the same period last year.
Strategic Developments: The company is focusing on long-term growth by expanding its pharmaceutical logistics through Hupan Pharmaceutical and forming partnerships with major e-commerce platforms, which has led to a 29.4% increase in Asia-based customer revenues in the first half of fiscal 2025.